Clinical Trials Browser

Unknown × Bendamustine Hydrochloride × Clear all

NCT01754402 2024-02-20

Bendamustine + Pomalidomide + Dex in R/R Multiple Myeloma

Phase 1/2 Unknown

56 enrolled 12 charts

Multiple Myeloma

NCT05757466 2023-12-19

Prolgo-HL

Phase 2 Unknown

Hodgkin Disease, Recurrence

NCT05979948 2023-09-14

CZ-WM01

Phase 2 Unknown

Waldenstrom Macroglobulinemia

NCT05287984 2022-03-31

ZFCR/ZBR

Phase 2 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT05006469 2021-08-16

Observation of the Efficacy of BAd Regimen in the Treatment of Relapsed and Refractory Multiple Myeloma

Phase 3 Unknown

Multiple Myeloma

NCT04934930 2021-06-22

FLMRD

Phase 2 Unknown

Lymphoma, Follicular

NCT04762745 2021-02-21

The Efficacy and Safety of Pomalidomide and Bendamustine With Dexamethasone in Relapsed or Refractory Multiple Myeloma

Phase 1/2 Unknown

Multiple Myeloma, Recurrence

NCT04127916 2020-03-18

Bendamustine Plus Rituximab for Mantle Cell Lymphoma: a Multicenter Retrospective Analysis(BR-MCL)

Lymphoma, Mantle-Cell

NCT02747732 2019-04-23

Study of Ibrutinib in Combination With Bendamustine and Rituximab for Patients With Relapsed/Refractory Aggressive BCL

Phase 2 Unknown

Neoplasms, Recurrence, Lymphoma, Large B-Cell, Diffuse

NCT03315520 2018-05-22

BeEAC-1

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Lymphoma, Non-Hodgkin

NCT02836639 2016-07-19

BEB Conditioning Regimen for Autologous Stem-cell Transplantation(ASCT) in Non-Hodgkin's Lymphoma

Phase 2 Unknown

Lymphoma, Non-Hodgkin

NCT02758925 2016-05-04

CyBeR-Lymph

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT02753062 2016-04-27

PTLD

Phase 2 Unknown

Lymphoma, Large B-Cell, Diffuse

NCT01412307 2015-08-11

LEBEN

Phase 1/2 Unknown

Hodgkin Disease

NCT02423837 2015-04-22

BRiF

Phase 3 Unknown

Lymphoma, Follicular

NCT02134262 2014-11-06

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Phase 1/2 Unknown

Burkitt Lymphoma, Immune System Diseases, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphomatoid Granulomatosis, Neoplasms, Neoplasms by Histologic Type, Neoplasms, Experimental, Recurrence, Lymphoma, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Lymphoma, Extranodal NK-T-Cell

NCT01884441 2014-01-29

Bendamustine, Gemcitabine and Vinorelbine (BeGEV) as Induction Therapy in Relapsed/Refractory Hodgkin's Lymphoma Patients

Phase 2 Unknown

Hodgkin Disease, Lymphoma, Recurrence

NCT01686386 2013-04-05

Study of Bendamustine, Lenalidomide and Low-dose Dexamethasone, for the Treatment of Patients With Relapsed Myeloma

Phase 1/2 Unknown

Multiple Myeloma, Recurrence

NCT01678430 2012-10-15

RIAltO

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, B-Cell

NCT01657955 2012-08-06

CLL

Phase 3 Unknown

LymphoidOther hematologic neoplasm

Leukemia, Neoplasms, Leukemia, Lymphocytic, Chronic, B-Cell

NCT01570049 2012-08-02

Safety and Efficacy Study of Bendamustine to Treat Non-Hodgkin Lymphoma

Phase 3 Unknown

Lymphoma, Non-Hodgkin

NCT01221103 2011-09-13

Dexamethasone, Ofatumumab and Bendamustine (DOT) First-line in Mantle-cell Lymphoma(MCL)

Phase 1/2 Unknown

Lymphoma, Non-Hodgkin, Lymphoma, Mantle-Cell

NCT01002703 2011-08-12

Treatment With Lenalidomide, Bendamustine and Prednisone (RBP) in Patients With Relapsed or Refractory Multiple Myeloma

Phase 1/2 Unknown

Multiple Myeloma, Neoplasms, Plasma Cell

NCT00385125 2006-10-06

Treatment of Patients With Relapsed or Primary Refractory Aggressive B- Cell NHL

Phase 2 Unknown

Lymphoma, Non-Hodgkin, Recurrence

NCT00168922 2006-04-27

Study to Determine the Efficacy of Bendamustin in Patients With Recurrent Small Cell Lung Cancer (SCLC)

Phase 2 Unknown

Small Cell Lung Carcinoma